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Background
Human rhinovirus is most prominently associated with
asthma exacerbations in humans. The U-BIOPRED pro-
ject of the Innovative Medicine Initiative (IMI) aims to
define biomarkers of asthma exacerbations. Within this
context, this study aimed to establish a mouse model of
asthma exacerbations induced by viral respiratory infec-
tion on the background of chronic allergic airway
inflammation.
Materials and methods
BALB/c mice were sensitized intranasally with house
dust mite (HDM) extract (25µg in 50µl saline) for five
days per week over 7 weeks. HRV1b was inoculated
intranasally on the final three challenge days 30 minutes
prior HDM application. Additionally, animals were trea-
ted with fluticasone proprionate daily prior to HDM
challenge in the final week to assess steroid efficacy. 24h
after the last combined virus/allergen challenge, pul-
monary function (lung resistance, RL) was measured
invasively to assess airway hyperresponsiveness (AHR)
against aerosolized methacholine (MCh). Bronchoalveo-
lar lavage (BAL) differential cell count and cytokines,
lung histology and mediastinal lymph node response
were analyzed.
Results
The HDM sensitized animals developed a marked aller-
gen-induced AHR and eosinophilic airway inflammation
compared to the saline control group. Additional rhino-
virus infection did not result in an exacerbation pheno-
type regarding AHR, BAL inflammatory cell counts,
draining lymph node cell counts and ex vivo prolifera-
tive response. However, a satellite control group of
naïve mice infected with HRV1B revealed an impaired
anti-viral immune response in animals with chronic air-
way inflammation, indicated by reduced BALF neutro-
phil cell counts and cytokine levels of IFN-g, IL-12, IL-
1b and TNF-a, as well as ex vivo proliferative response
of draining lymph node cells.
Conclusions
The established model of combined chronic airway
inflammation and viral infection failed to mimic the
symptoms of exacerbating asthma pathology. Neverthe-
less, this model was able to show in vivo the impaired
anti-viral immune response due to chronic allergic air-
way inflammation. The failure to induce exacerbation
might be due to inefficient replication of rhinovirus in
the mouse, therefore the use of other respiratory viruses
might succeed in developing exacerbation models. How-
ever, the observed impaired anti-viral response in mice
with chronic airway inflammation might reflect the basis
for an altered progress of the disease, ultimately result-
ing in a more severe phenotype.
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